BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12195960)

  • 21. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2.
    Hernández GL; Volpert OV; Iñiguez MA; Lorenzo E; Martínez-Martínez S; Grau R; Fresno M; Redondo JM
    J Exp Med; 2001 Mar; 193(5):607-20. PubMed ID: 11238591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3-Nitroasterric Acid Derivatives from an Antarctic Sponge-Derived Pseudogymnoascus sp. Fungus.
    Figueroa L; Jiménez C; Rodríguez J; Areche C; Chávez R; Henríquez M; de la Cruz M; Díaz C; Segade Y; Vaca I
    J Nat Prod; 2015 Apr; 78(4):919-23. PubMed ID: 25732560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation.
    Verheul HM; Hoekman K; Jorna AS; Smit EF; Pinedo HM
    Oncologist; 2000; 5 Suppl 1():45-50. PubMed ID: 10804091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells.
    Sartippour MR; Shao ZM; Heber D; Beatty P; Zhang L; Liu C; Ellis L; Liu W; Go VL; Brooks MN
    J Nutr; 2002 Aug; 132(8):2307-11. PubMed ID: 12163680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action.
    Waltenberger J; Mayr U; Frank H; Hombach V
    J Mol Cell Cardiol; 1996 Jul; 28(7):1523-9. PubMed ID: 8841939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tranilast inhibits protein kinase C-dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells.
    Koyama S; Takagi H; Otani A; Suzuma K; Nishimura K; Honda Y
    Br J Pharmacol; 1999 May; 127(2):537-45. PubMed ID: 10385256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors.
    Kojima-Yuasa A; Hua JJ; Kennedy DO; Matsui-Yuasa I
    Life Sci; 2003 Jul; 73(10):1299-313. PubMed ID: 12850245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
    Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities.
    Koyanagi S; Tanigawa N; Nakagawa H; Soeda S; Shimeno H
    Biochem Pharmacol; 2003 Jan; 65(2):173-9. PubMed ID: 12504793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orally administered bovine lactoferrin systemically inhibits VEGF(165)-mediated angiogenesis in the rat.
    Norrby K; Mattsby-Baltzer I; Innocenti M; Tuneberg S
    Int J Cancer; 2001 Jan; 91(2):236-40. PubMed ID: 11146451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis.
    Binétruy-Tournaire R; Demangel C; Malavaud B; Vassy R; Rouyre S; Kraemer M; Plouët J; Derbin C; Perret G; Mazié JC
    EMBO J; 2000 Apr; 19(7):1525-33. PubMed ID: 10747021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
    Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody.
    Zhu Z; Lu D; Kotanides H; Santiago A; Jimenez X; Simcox T; Hicklin DJ; Bohlen P; Witte L
    Cancer Lett; 1999 Mar; 136(2):203-13. PubMed ID: 10355750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azaspirene: a novel angiogenesis inhibitor containing a 1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione skeleton produced by the fungus Neosartorya sp.
    Asami Y; Kakeya H; Onose R; Yoshida A; Matsuzaki H; Osada H
    Org Lett; 2002 Aug; 4(17):2845-8. PubMed ID: 12182570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.
    Shimamura M; Nagasawa H; Ashino H; Yamamoto Y; Hazato T; Uto Y; Hori H; Inayama S
    Br J Cancer; 2003 Jan; 88(2):307-13. PubMed ID: 12610518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.
    Papapetropoulos A; García-Cardeña G; Madri JA; Sessa WC
    J Clin Invest; 1997 Dec; 100(12):3131-9. PubMed ID: 9399960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo.
    Mantell DJ; Owens PE; Bundred NJ; Mawer EB; Canfield AE
    Circ Res; 2000 Aug; 87(3):214-20. PubMed ID: 10926872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationship and biological property of cortistatins, anti-angiogenic spongean steroidal alkaloids.
    Aoki S; Watanabe Y; Tanabe D; Arai M; Suna H; Miyamoto K; Tsujibo H; Tsujikawa K; Yamamoto H; Kobayashi M
    Bioorg Med Chem; 2007 Nov; 15(21):6758-62. PubMed ID: 17765550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.